$456,500,000 in Total Settlement Funds Available. See if you qualify!Find Out More

News Board

Stay informed with the latest in settlement notices, case updates, publications, analyst reports, and more.

Required Field

Loading...

Learn More

CGC Investors Sue After Margins Let Down
 Canopy Growth gave investors a major high when it said it was rolling in the green and margins were expanding.  So, it was a big buzz kill when investors discovered not only were Canopy’s margins down, but its shipping costs were out of control, too.  Disappointed investors burned their Canopy shares, sending the stock’s price...Read more

May 12, 2025

Learn More

Bad MER Buyout Sparks SEI Investors Lawsuit
Solaris Energy left investors in the dark when it bought out a company with no employees, no turbines, and no track record.  When investors saw the light, they shut off their Solaris shares, sending the stock’s price crashing almost seventeen percent.  Now, some investors have filed a class action against the Company.  Solaris Energy provides...Read more

May 8, 2025

Learn More

Investors Pull Plug on SANA After Research Bombshell
When Sana announced it ran out of cash to research its cancer drugs, investors ran out of patience.  Investors dumped their shares, causing Sana’s stock price to fall 10%.  Now, Sana’s shareholders are fighting back with a class-action. In 2023, Sana had three major drug candidates, including two cancer-fighting agents.  Sana told investors it had...Read more

May 7, 2025

Learn More

ZYXI Insurance Fraud Burns Investors
When insurance companies zapped Zynex for massive insurance fraud, its revenues plummeted.  Shocked investors dumped their shares and Zynex’s stock lost fifty-one percent overnight.   Now those investors are fighting back with a class action against Zynex.  Zynex makes electrotherapy devices for pain management and its revenue depends on insurance reimbursements.  Throughout 2020 to 2024, Zynex...Read more

May 6, 2025

Learn More

UTCC Loses on China; Investors Sue
Ultra Clean Holdings isn’t so squeaky clean after it revealed “unexpected softness” in the Chinese market.  Infuriated investors took Ultra Clean stock to the cleaners after this revelation, sending for it a 28% nosedive.  Now, some investors have filed a class action to recover their losses. Ultra Clean manufacturers contamination control technologies for precision industries. ...Read more

May 6, 2025

Learn More

SOUN Material Weakness Causes Investor Lawsuit
SoundHound uses artificial intelligence to create artificial voices, but it turns out its assets were artificial, too.  When investors learned SoundHound had to make millions of dollars in accounting adjustments due to major bookkeeping errors, shareholders rapidly dumped their stock.  Some of those investors are fighting back with class action against the Company. In t2024,...Read more

May 5, 2025

Learn More

FDA Questions ANTM Study; Investors Sue
After Actinium revealed the FDA was years away from approving Actinium’s key drug, investors raced for the exits, sending Actinium’s stock price crashing by 60% in one day.  Now investors are taking legal action to recover their losses. Actinium is a pharma company investigating Iomab-B, a cancer-fighting drug.  In 2016, Actinium launched Sierra, a Phase...Read more

May 2, 2025

Learn More

Court Appoints Levi & Korsinsky in RIG Case
Gabor v. Transocean Ltd., et al and Matteson v. Transocean Ltd., et al are securities class action cases pending before the U.S. District Court, Southern District of New York.   In both cases, Plaintiffs bring securities fraud allegations against Transocean and some of its executives.  The Plaintiffs allege defendants made false and misleading statements about Transocean’s...Read more

April 28, 2025

Learn More

EU Stocks Freefall After Material Weaknesses Revealed
enCore Energy hit rock bottom when it revealed a sixty-three million loss and material weaknesses in its internal controls.  Furious investors ditched their enCore shares, crashing the Company’s stock price crashing by 46%.  Now, investors are fighting back with a class action.  enCore is a uranium energy company.  Throughout 2024, it filed SEC papers reassuring...Read more

April 24, 2025

Learn More

L&K Associate Michael Pollack Speaks at NYU Panel
On April 8, 2025, Levi & Korsinsky associate Michael Pollack joined the NYU Plaintiffs’ Law Association Career Panel at Vanderbilt Hall, where he outlined the Firm’s class action practice and the strategic considerations that drive plaintiff‑side litigation. Speaking alongside other practitioners, Michael discussed client interactions, long-term career strategies, motion practice, and the skills students need to succeed...Read more

April 23, 2025

Learn More

PPTA Investors Sue After Costs Skyrocket
Investors were left holding fool’s gold after Perpetua Resources increased capital expenses 75%, despite reassurances everything was okay  Perpetua’s stock price caved in after its investors rapidly sold off their shares, sending the Company’s shares plunging by 22%.  Now, furious investors are suing the company to recover their losses.  Perpetua is revamping an Idaho gold...Read more

April 22, 2025

Learn More

TFII Crashes Out and Investors Fight Back
Shipping giant TFI crashed out when it revealed its trucking business had been on the decline for a year, but Company executives hid the fact from stockholders.  When they learned the truth, enraged investors dumped their shares, causing TFI’s stock price to plummet 20% in just a day.  Now, those investors are fighting back with...Read more

April 18, 2025

Learn More

Levi & Korsinsky to Represent TIXT Investors
Sarria v. Telus International (CDA) Inc., case no. 1:25-cv-00889-DM, is a case currently pending before the U.S. District Court, Southern District of New York.  The action was filed on behalf of investors in Telus International (CDA), Inc. (NYSE: TIXT) who allegedly suffered losses due to fraud committed by the Company and its executives.   On...Read more

April 17, 2025

Learn More

Rytelo Sales Stall; GERN Investors Take Legal Action
When Geron’s revenue flatlined, investors pulled the plug on their shares, sending the Company’s stock price plummeting 32% overnight.   Now those investors are fighting back with a class-action lawsuit against Geron. Geron is a pharmaceutical company which developed the drug Rytelo.  In 2024, Geron announced it would be launching Rytelo and was confident it would...Read more

April 16, 2025

Learn More

FLNC Hit with Investor Lawsuit After Dire Earnings Report
After Fluence Energy slashed its revenue guidance, many investors ditched their shares.  Fluence’s stock price crashed a whopping 47% overnight.  Now, investors are fighting back with a class-action lawsuit against the Company.   Fluence is a joint venture between Seimens and AED, which are also Fluence’s two biggest customers.  So things got bad for Fluence when...Read more

April 15, 2025

View Older News

Loading...